Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
42.98M
Dividend Yield
0.00%
P/E Ratio
-1.06
EPS
-0.72
Revenue
9.29M
Avg. Volume
71.69K

Recently from Cashu

publisher logo
Cashu

Cue Biopharma: Innovative Advances in Targeted Immunotherapy Solutions for Better Patient Outcomes

3 days ago

About

What does CUE do?
Cue Biopharma, a Boston-based clinical-stage biopharmaceutical company, develops biologic drugs for immune system modulation to treat cancers and autoimmune disorders. Its key candidates include CUE-101 for HPV-positive HNSCC and CUE-102 for Wilms' Tumor 1 protein.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Massachusetts, USA
Website
http://www.cuebiopharma.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
cue
Cue Biopharma
CUE
0.00 (+0.46%)
0.6952
USD
At close at Jul 04, 16:44 UTC
Summary
News
Signals
Benchmarks
Financials